Publication Name	World Journal of Diabetes
Manuscript ID	68406
Country	France

Received	2021-05-21 17:17
Peer-Review Started	2021-05-21 17:20
To Make the First Decision
Return for Revision	2021-06-16 14:33
Revised	2021-06-29 13:27
Second Decision	2021-08-31 03:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-31 09:54
Articles in Press	2021-08-31 09:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-26 03:03
Publish the Manuscript Online	2021-10-13 08:37

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Interactions between diabetes and COVID-19: A narrative review
Manuscript Source	Invited Manuscript
All Author List	Sophia Sabri, Olivier Bourron, Franck Phan and Lee S Nguyen
Funding Agency and Grant Number
Corresponding Author	Lee S Nguyen, MD, PhD, Doctor, Doctor, Senior Researcher, Research and Innovation, RICAP, CMC Ambroise Paré, 25-27 Boulevard Victor Hugo, Neuilly-sur-Seine 92200, France. nguyen.lee@icloud.com
Key Words	COVID-19; Corticosteroids; Steroid-induced diabetes; Renin-angiotensin system; Prognosis
Core Tip	Diabetes features complex interactions with the severe acute respiratory disease coronavirus-2 (SARS-CoV-2). Diabetic patients are at higher risk of severe infections. They often present associated comorbidities such as obesity, hypertension and cardiovascular diseases, and complications of diabetes, including chronic kidney disease, vasculopathy and relative immune dysfunction. Additionally, corticosteroids, which count among the few medications which showed benefit on survival are associated to new onsets of diabetes, and metabolic disorders in patients with previous history of diabetes. Finally, SARS-CoV-2 via the alternate effects of the renin-angiotensin system, mediated by the angiotensin-converting-enzyme 2, was also associated with insulin resistance.
Publish Date	2021-10-13 08:37
Citation	Sabri S, Bourron O, Phan F, Nguyen LS. Interactions between diabetes and COVID-19: A narrative review. World J Diabetes 2021; 12(10): 1674-1692
URL	https://www.wjgnet.com/1948-9358/full/v12/i10/1674.htm
DOI	https://dx.doi.org/10.4239/wjd.v12.i10.1674

Full Article (PDF)	WJD-12-1674.pdf
Full Article (Word)	WJD-12-1674.docx
Manuscript File	68406_Auto_Edited-JLW.docx
Answering Reviewers	68406-Answering reviewers.pdf
Audio Core Tip	68406-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	68406-Conflict-of-interest statement.pdf
Copyright License Agreement	68406-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	68406-Language certificate.pdf
Peer-review Report	68406-Peer-review(s).pdf
Scientific Misconduct Check	68406-Scientific misconduct check.pdf
Scientific Editor Work List	68406-Scientific editor work list.pdf
CrossCheck Report	68406-CrossCheck report.pdf